Page last updated: 2024-08-23

androstane-3,17-diol and Uterine Neoplasms

androstane-3,17-diol has been researched along with Uterine Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Poortman, J; Schwarz, F; Thijssen, JH; Vroegindewey-Jie, D	1

Other Studies

1 other study(ies) available for androstane-3,17-diol and Uterine Neoplasms

Article	Year
Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue. Molecular and cellular endocrinology, 1977, Volume: 8, Issue:1 Topics: Androstane-3,17-diol; Androstanes; Androstenediols; Androstenedione; Breast Neoplasms; Cytosol; Estradiol; Female; Humans; Myometrium; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship; Testosterone; Uterine Neoplasms	1977

Article

Year

Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue.

Molecular and cellular endocrinology, 1977, Volume: 8, Issue:1

Topics: Androstane-3,17-diol; Androstanes; Androstenediols; Androstenedione; Breast Neoplasms; Cytosol; Estradiol; Female; Humans; Myometrium; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship; Testosterone; Uterine Neoplasms

1977